Heart failure drug jardiance tested against standard care in 5,000 patients
NCT ID NCT07044700
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 22 times
Summary
This study looks at how well the drug Jardiance works compared to usual heart failure treatments in 5,000 adults in China with a type of heart failure called HFrEF. The goal is to see if Jardiance reduces the risk of death from heart problems or hospital stays for heart failure. Participants will be followed in real-world clinics, and their health outcomes will be tracked over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital; National Center for Cardiovascular Diseases
Beijing, 100037, China
Conditions
Explore the condition pages connected to this study.